As of November 2026 Theravance Biopharma has a market cap of โน83.32 Billion. This makes Theravance Biopharma the world's 6487th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.